Tags

Type your tag names separated by a space and hit enter

[Yellow fever].
Przegl Epidemiol. 2004; 58 Suppl 1:101-5.PE

Abstract

Yellow fever is a mosquito born viral illness that causes hemorrhagic fever in tropical Africa and South America. An estimated 200 000 people are still infected annually. There is no antiviral therapy available and vaccination is major strategy in the control yellow fever. From 60 years ago is available very safe and efficient vaccine. The vaccine is a live attenuated virus strain 17D. Recently identified vaccine associated viscerotropic diseases (YFV-AVD). This paper describes knowledge about yellow fever disease, vaccine associated adverse events and actually recommendation for vaccine use.

Authors+Show Affiliations

Wiercińska-Drapało A
Klinika Obserwacyjno-Zakaźna Akademii Medycznej w Białymstoku.

MeSH

Central AmericaDose-Response Relationship, ImmunologicHumansMass VaccinationSouth AmericaVaccines, AttenuatedYellow FeverYellow Fever Vaccine

Pub Type(s)

English Abstract
Journal Article
Review

Language

pol

PubMed ID

15807166

Citation

Wiercińska-Drapało, Alicja. "[Yellow Fever]." Przeglad Epidemiologiczny, vol. 58 Suppl 1, 2004, pp. 101-5.
Wiercińska-Drapało A. [Yellow fever]. Przegl Epidemiol. 2004;58 Suppl 1:101-5.
Wiercińska-Drapało, A. (2004). [Yellow fever]. Przeglad Epidemiologiczny, 58 Suppl 1, 101-5.
Wiercińska-Drapało A. [Yellow Fever]. Przegl Epidemiol. 2004;58 Suppl 1:101-5. PubMed PMID: 15807166.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Yellow fever]. A1 - Wiercińska-Drapało,Alicja, PY - 2005/4/6/pubmed PY - 2005/5/28/medline PY - 2005/4/6/entrez SP - 101 EP - 5 JF - Przeglad epidemiologiczny JO - Przegl Epidemiol VL - 58 Suppl 1 N2 - Yellow fever is a mosquito born viral illness that causes hemorrhagic fever in tropical Africa and South America. An estimated 200 000 people are still infected annually. There is no antiviral therapy available and vaccination is major strategy in the control yellow fever. From 60 years ago is available very safe and efficient vaccine. The vaccine is a live attenuated virus strain 17D. Recently identified vaccine associated viscerotropic diseases (YFV-AVD). This paper describes knowledge about yellow fever disease, vaccine associated adverse events and actually recommendation for vaccine use. SN - 0033-2100 UR - https://www.unboundmedicine.com/medline/citation/15807166/[Yellow_fever]_ L2 - https://www.diseaseinfosearch.org/result/7583 DB - PRIME DP - Unbound Medicine ER -